Form D · Biotechnology
Bench7 Inc.
Bismarck, ND · CIK 0002062359
Offering snapshot reported Mar 20, 2025 · SEC filing
- Reported sold
- $100K Offering amount: $100K
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Mar 11, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 20, 2025 | Initial | $100,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-541538
Source: Form D, filed Mar 20, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Chris James Pearce | Director, Executive |
| John Persson | Director, Executive |
| Jesse Weiand | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
929 Parkview Drive
Bismarck, ND, 58501
Bismarck, ND, 58501